Current Ratio of Akero Therapeutics, Inc. from 31 Mar 2020 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Akero Therapeutics, Inc. quarterly Current Ratio in % history and change rate from 31 Mar 2020 to 30 Sep 2025.
  • Akero Therapeutics, Inc. Current Ratio for the quarter ending 30 Sep 2025 was 1578%, a 35% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

Akero Therapeutics, Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q3 2025 1578% -839% -35% 30 Sep 2025
Q2 2025 1611% -979% -38% 30 Jun 2025
Q1 2025 1919% -787% -29% 31 Mar 2025
Q4 2024 2218% -259% -10% 31 Dec 2024
Q3 2024 2418% +178% +7.9% 30 Sep 2024
Q2 2024 2590% +503% +24% 30 Jun 2024
Q1 2024 2706% +1264% +88% 31 Mar 2024
Q4 2023 2477% +1312% +113% 31 Dec 2023
Q3 2023 2240% +1308% +140% 30 Sep 2023
Q2 2023 2087% +1299% +165% 30 Jun 2023
Q1 2023 1442% +503% +53% 31 Mar 2023
Q4 2022 1165% -40% -3.3% 31 Dec 2022
Q3 2022 931% -626% -40% 30 Sep 2022
Q2 2022 787% -1265% -62% 30 Jun 2022
Q1 2022 940% -1116% -54% 31 Mar 2022
Q4 2021 1206% -641% -35% 31 Dec 2021
Q3 2021 1558% -128% -7.6% 30 Sep 2021
Q2 2021 2052% +535% +35% 30 Jun 2021
Q1 2021 2055% +72% +3.6% 31 Mar 2021
Q4 2020 1846% 31 Dec 2020
Q3 2020 1686% 30 Sep 2020
Q2 2020 1517% 30 Jun 2020
Q1 2020 1983% 31 Mar 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.